Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
暂无分享,去创建一个
E. Vokes | R. Rosenberg | R. Gralla | S. Jones | M. Jahanzeb | C. Belani | J. Bigley | J. Hohneker | J. Craig | J. Craig
[1] F. Invernizzi,et al. Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature. , 1994, Chest.
[2] P Chomy,et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Oxman,et al. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. Kaasa,et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis , 1993, The Lancet.
[5] M. Green,et al. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] T. Delozier,et al. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G Cartei,et al. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. , 1993, Journal of the National Cancer Institute.
[8] J. Crowley,et al. Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] M. Grever,et al. New chemotherapeutic agents in non-small-cell lung cancer. , 1993, Seminars in oncology.
[10] J. Herndon,et al. Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] E. Quoix,et al. [Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study]. , 1991, Bulletin du cancer.
[12] D. Finkelstein,et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] R. Holle,et al. Experience of a German multicenter study group with ifosfamide in small cell lung cancer. , 1989, Seminars in oncology.
[14] J L Pater,et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] K. Propert,et al. Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study. , 1987, Cancer treatment reports.
[16] D. Ettinger,et al. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] M Lavandier,et al. Benefits of polychemotherapy in advanced non‐small‐cell bronchogenic carcinoma , 1982, Cancer.